Mark S. Schroeder - 04 Feb 2023 Form 4 Insider Report for LABORATORY CORP OF AMERICA HOLDINGS (LH)

Role: EVP, President-Diagnostics Lab
Signature: /s/ Sandra D. van der Vaart, Attorney-in-Fact for Mark S. Schroeder
Issuer symbol: LH
Transactions as of: 04 Feb 2023
Net transactions value: -$36,920
Form type: 4
Filing time: 07 Feb 2023, 13:50:16 UTC
Previous filing: 06 Feb 2023
Next filing: 09 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LH	Common Stock	Options Exercise		+560	+8.4%		7,247	04 Feb 2023	Direct	F1
transaction	LH	Common Stock	Tax liability	$36,920	-151	-2.1%	$244.50	7,096	06 Feb 2023	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LH	Restricted Stock Unit	Options Exercise	$0	-560	-25%	$0.000000	1,714	04 Feb 2023	Common Stock	560		Direct	F1, F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F2	Stock withholding to satisfy tax withholding obligations.
F3	The Restricted Stock Units vested in three equal annual installments beginning on February 4, 2021 and are now fully vested.
F4	This number reflects the aggregate number of Restricted Stock Units held by the reporting person.